AGL 37.98 Increased By ▲ 0.48 (1.28%)
AIRLINK 221.50 Decreased By ▼ -1.39 (-0.62%)
BOP 10.77 Decreased By ▼ -0.05 (-0.46%)
CNERGY 7.46 Decreased By ▼ -0.10 (-1.32%)
DCL 9.30 Decreased By ▼ -0.12 (-1.27%)
DFML 40.70 Decreased By ▼ -0.26 (-0.63%)
DGKC 104.60 Decreased By ▼ -2.16 (-2.02%)
FCCL 36.28 Decreased By ▼ -0.79 (-2.13%)
FFL 19.37 Increased By ▲ 0.13 (0.68%)
HASCOL 13.13 Decreased By ▼ -0.05 (-0.38%)
HUBC 131.50 Decreased By ▼ -1.14 (-0.86%)
HUMNL 14.39 Decreased By ▼ -0.34 (-2.31%)
KEL 5.21 Decreased By ▼ -0.19 (-3.52%)
KOSM 7.50 Increased By ▲ 0.02 (0.27%)
MLCF 46.90 Decreased By ▼ -1.28 (-2.66%)
NBP 65.60 Decreased By ▼ -0.69 (-1.04%)
OGDC 221.15 Decreased By ▼ -2.11 (-0.95%)
PAEL 44.65 Increased By ▲ 1.15 (2.64%)
PIBTL 9.05 Decreased By ▼ -0.02 (-0.22%)
PPL 195.00 Decreased By ▼ -3.24 (-1.63%)
PRL 41.72 Decreased By ▼ -0.52 (-1.23%)
PTC 26.98 Decreased By ▼ -0.41 (-1.5%)
SEARL 109.30 Decreased By ▼ -0.78 (-0.71%)
TELE 10.40 Decreased By ▼ -0.12 (-1.14%)
TOMCL 36.11 Decreased By ▼ -0.51 (-1.39%)
TPLP 14.71 Decreased By ▼ -0.24 (-1.61%)
TREET 26.14 Decreased By ▼ -0.39 (-1.47%)
TRG 67.90 Decreased By ▼ -0.95 (-1.38%)
UNITY 33.79 Decreased By ▼ -0.40 (-1.17%)
WTL 1.77 Decreased By ▼ -0.02 (-1.12%)
BR100 12,342 Decreased By -21.8 (-0.18%)
BR30 37,796 Decreased By -422.2 (-1.1%)
KSE100 117,031 Decreased By -88.2 (-0.08%)
KSE30 36,918 Decreased By -19.2 (-0.05%)

BELGRADE: Serbia is starting to produce Russia’s Sputnik V coronavirus vaccine, President Aleksandar Vucic said on Friday, the first European nation outside Russia and Belarus to take the step.

Vucic said he and Russian counterpart Vladimir Putin would watch via video link as the first vials are filled in Belgrade.

“In a few days you will have Serbian jabs that we will be able to offer to our citizens but also... around the world,” he told journalists.

A similar project is planned with China’s Sinopharm vaccine, Vucic added.

Four million Sputnik V jabs should be turned out over the next four to six months, officials have said.

The Russian jab has now been registered for use in more than 65 countries but has yet to be approved by the EU or US health authorities.

Comments

Comments are closed.